GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Azenta Inc (FRA:BA3) » Definitions » Cyclically Adjusted Revenue per Share

Azenta (FRA:BA3) Cyclically Adjusted Revenue per Share : €8.36 (As of Mar. 2025)


View and export this data going back to 1995. Start your Free Trial

What is Azenta Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Azenta's adjusted revenue per share for the three months ended in Mar. 2025 was €2.901. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €8.36 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Azenta's average Cyclically Adjusted Revenue Growth Rate was 6.10% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 5.50% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 2.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Azenta was 5.50% per year. The lowest was -9.30% per year. And the median was -2.65% per year.

As of today (2025-05-22), Azenta's current stock price is €24.00. Azenta's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was €8.36. Azenta's Cyclically Adjusted PS Ratio of today is 2.87.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Azenta was 15.86. The lowest was 1.01. And the median was 4.76.


Azenta Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Azenta's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Azenta Cyclically Adjusted Revenue per Share Chart

Azenta Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.81 6.78 8.38 8.17 8.27

Azenta Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.10 8.27 8.27 8.89 8.36

Competitive Comparison of Azenta's Cyclically Adjusted Revenue per Share

For the Medical Instruments & Supplies subindustry, Azenta's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Azenta's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Azenta's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Azenta's Cyclically Adjusted PS Ratio falls into.


;
;

Azenta Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Azenta's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=2.901/134.9266*134.9266
=2.901

Current CPI (Mar. 2025) = 134.9266.

Azenta Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 1.883 100.684 2.523
201509 1.892 100.392 2.543
201512 1.616 99.792 2.185
201603 1.772 100.470 2.380
201606 1.898 101.688 2.518
201609 0.405 101.861 0.536
201612 2.170 101.863 2.874
201703 2.257 102.862 2.961
201706 2.297 103.349 2.999
201709 0.194 104.136 0.251
201712 1.700 104.011 2.205
201803 1.803 105.290 2.311
201806 2.079 106.317 2.638
201809 1.928 106.507 2.442
201812 2.185 105.998 2.781
201903 2.429 107.251 3.056
201906 2.490 108.070 3.109
201909 -3.095 108.329 -3.855
201912 2.572 108.420 3.201
202003 2.701 108.902 3.346
202006 2.649 108.767 3.286
202009 -3.008 109.815 -3.696
202012 1.307 109.897 1.605
202103 1.465 111.754 1.769
202106 1.442 114.631 1.697
202109 1.547 115.734 1.804
202112 1.651 117.630 1.894
202203 1.763 121.301 1.961
202206 1.674 125.017 1.807
202209 1.854 125.227 1.998
202212 2.321 125.222 2.501
202303 2.006 127.348 2.125
202306 2.415 128.729 2.531
202309 2.713 129.860 2.819
202312 2.292 129.419 2.390
202403 2.263 131.776 2.317
202406 3.031 132.554 3.085
202409 3.195 133.029 3.241
202412 3.088 133.157 3.129
202503 2.901 134.927 2.901

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Azenta  (FRA:BA3) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Azenta's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=24.00/8.36
=2.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Azenta was 15.86. The lowest was 1.01. And the median was 4.76.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Azenta Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Azenta's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Azenta Business Description

Industry
Traded in Other Exchanges
Address
200 Summit Drive, 6th Floor, Burlington, MA, USA, 01803
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.

Azenta Headlines

No Headlines